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or other birds die. Those who knew
about H5N1 influenza told me that,
without adequate compensation for
culling flocks, little incentive would
exist to report bird deaths. In a typical
village, chickens, ducks, and pigs
intermingled with each other and with
humans underneath or around homes
on stilts. General knowledge of infec-
tion control practices among villagers
was minimal.
The dissemination of information
into a rural, agricultural society such
as that in the southeast of Cambodia is
a difficult task. Many rural inhabitants
do not have televisions or radios and
may infrequently travel to larger
towns. Health workers from interna-
tional groups, nongovernmental
organizations, and the government are
often required to travel on foot or
motorbike through fields and forests to
reach and educate the population.
Government health workers lack the
personnel and resources to adequately
identify and investigate potential
cases, and Cambodia has substantially
fewer microbiology laboratories than
do neighboring Thailand and Vietnam.
Should a pandemic of avian
influenza occur, it will almost certain-
ly originate in Southeast Asia.
Cambodian and international health
organizations have recognized the
country’s potential key role in propa-
gation of an impending pandemic
agent. However, because of its history
and current economic state, Cambodia
is less able to respond to the avian
influenza threat than its neighbors. In
recognition of this fact, the World
Health Organization and the
Cambodian Ministry of Health have
stated that the prevention, control, and
identification of avian influenza are
national priorities. Additionally, inter-
national funds have been flowing into
Cambodia to assist with avian H5N1
influenza surveillance and case inves-
tigation. Much work remains to be
done; we hope that by combining
international resources and policy
with domestic expertise and effort,
Cambodia will mount a successful
response against this emerging threat.
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Helicobacter 
pylori and Immuno-
compromised
Children
To the Editor: Helicobacter
pylori has been classified as a carcino-
genic pathogen. Its prevalence is high
in developing countries. Apart from
the known gastrointestinal pathologic
changes caused by this organism,
reports on the association between H.
pylori infection and extragastro-
intestinal diseases have been increas-
ing. Although impaired host immuni-
ty should be associated with a high
prevalence of this infection, a defini-
tive relationship has not been estab-
lished. We conducted a cross-section-
al study to determine the prevalence
of H. pylori infection in immunocom-
promised Thai children. 
The study was reviewed and
approved by the research ethic com-
mittee of Chiang Mai University.
From 2003 to 2004, a total of 60 chil-
dren <18 years of age, who received
corticosteroids, immunosuppressive
drugs, or both, were enrolled consec-
utively into this study. Patients who
had taken proton pump inhibitors and
antimicrobial drugs 2 weeks before
the study began were excluded. Stool
specimens were collected and imme-
diately stored at –20°C before analy-
sis with the H. pylori stool antigen test
(Meridian Bioscience Inc., Cincinnati,
OH, USA). Although no study has
validated this test in Thai children,
most studies report its high sensitivity
and specificity (>90%) (1). 
The children enrolled in the study
had a mean age of 7.9 years (range
0.5–16.6) and most were receiving
both corticosteroids and chemothera-
py (n = 36). Fourteen patients were
being treated exclusively with corti-
costeroids, and 10 patients were
receiving only chemotherapy. A total
of 17.4% of the children <5 years of
age had H. pylori infection, and the
overall prevalence was 20%.
Although we observed a relatively
high prevalence of infection in
patients with malignancy, particularly
leukemia, the trend did not reach sta-
tistical significance (Table).
In contrast to previous studies that
reported a low prevalence of infection
with H. pylori in patients with AIDS
(2) and leukemia (3), we demonstrated
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that its prevalence in immunocompro-
mised Thai children (20%) was higher
than that previously reported in a
healthy Thai population (17.5%) (4)
and in those with recurrent abdominal
pain (11.3%) (5). The prevalence in
children <5 years of age was high
compared with that reported from
Perez-Perez et al. (17.4% vs. 5%) (4).
Although unintentional eradication of
H. pylori after multiple courses of
antimicrobial drugs in such patients
could explain the low prevalence in
some studies, commonly prescribed
antimicrobial drugs without antisecre-
tory agents may be unable to cure the
infection.
The major limitations of this pre-
liminary study were the use of differ-
ent diagnostic methods in the various
studies and the lack of healthy con-
trols. Thus, a well-designed case-con-
trol study is needed. However, the
prevalence of infection with H. pylori
in the immunocompromised children
was high, and these patients appear to
be more susceptible to this infection
in early life. 
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Community Case 
of Methicillin-
resistant
Staphylococcus
aureus Infection
To the Editor: Community-asso-
ciated methicillin-resistant Staphylo-
coccus aureus (CA-MRSA) is an
emerging infectious disease world-
wide and is increasingly reported in
Asia (1). We describe a community
case of invasive MRSA infection,
which appeared as bacteremia and
pneumonia; CA-MRSA was initially
suspected, and eventually the patient
was treated successfully with ampi-
cillin/sulbactam. 
A 52-year-old man with chronic
eczema was admitted to the Prince of
Wales Hospital, Hong Kong, with
fever and chills. Before admission, he
had been treated for infected eczema-
tous lesions for several weeks with
oral ampicillin, cloxacillin, and cefa-
zolin. He had no history of hospital-
ization in the past 10 years, and none
of his family members were health-
care workers. Examination showed an
oral temperature of 40°C, blood pres-
sure 95/55 mm Hg, and no audible
murmur. Cellulitis in the left leg com-
plicated his eczematous skin lesions.
Chest radiograph showed right-mid-
dle-zone pneumonia. Neutrophilia
(leukocytes 15.5 × 109/L, neutrophils
86%), thrombocytopenia (platelets 55
× 109/L), prolonged activated partial
thromboplastin time (43.6 s), and ele-
vated bilirubin level (31 µmol/L)
were observed. Two initial blood cul-
tures grew gram-positive cocci in
clusters, identified as S. aureus by
positive results for catalase and
slide/tube coagulase and a negative
result for ornithine decarboxylase.
Intravenous cloxacillin (2 g every 6 h)
was given on days 2–5. Antimicrobial
drug susceptibility testing was per-
formed by the disk-diffusion method
(1  µg oxacillin/disk, Mueller-Hinton
agar, 2% NaCl), followed by MIC
determination with the agar dilution
method in accordance with NCCLS
(former National Committee for
Clinical Laboratory Standards, now
Clinical and Laboratory Standards
Institute) recommendations (2). One
blood isolate was identified as methi-
cillin-resistant  S. aureus  (MRSA),
with an oxacillin MIC 4 µg/mL. The
other isolate was identified as methi-
cillin-sensitive  S.  aureus (MSSA),
with an oxacillin MIC of 0.5 µg/mL.
In view of a possible CA-MRSA
infection (which could have been β-
lactam–resistant), cloxacillin was sub-
stituted with intravenous vancomycin
plus rifampin on day 5. 
However, the patient’s condition
progressively deteriorated from day 2
to day 10 with persistent fever, chills,
hypotension, and hemoptysis. A
repeated chest radiograph showed
small lung cavities with fluid, and a
thoracic computed tomographic scan
confirmed multiple lung abscesses.
Results of an initial transthoracic
echocardiograph were normal, but a
subsequent transesophageal echocar-
diograph demonstrated tricuspid
valve vegetation.
The MRSA isolate was susceptible
to gentamicin, cotrimoxazole, erythro-
mycin, ciprofloxacin, clindamycin,
fusidic acid, tetracycline, chloram-
phenicol,vancomycin, and rifampin; a
different pattern of multidrug-resistant
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